Answers are grounded in this paper and cite their sources.
mice. Our findings suggest that genetically engineered iNSCs could potentially be used to deliver enzymes and treat MPS IIIB.
No takes yet. Share an insight, caveat, or question.
Clarke et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: